News Novo Nordisk returns to ABPI fold after two-year suspension Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."
News EMA abandons X in favour of rival Bluesky The EMA has abandoned X for Bluesky, saying Elon Musk's social media platform "no longer suits our communication needs."
Sales & Marketing Unpacking EASD 2024: Key themes, topics, and influencers This September, Madrid played host to the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD).
Sales & Marketing Creative review: The Cannes Lions trends that pharma needs t... Pharma creative needs to stand up and be counted.
Digital DIA 2024: Charting new horizons in patient-centered R&D In its 60th year, the Drug Information Association (DIA) global annual meeting
Market Access Deepening perspectives: How social media is driving our unde... On the 31st of May, news broke that the NHS was launching its “world-first” cancer vaccine matchmaking programme.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.